• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis.

作者信息

Compston J E, Audran M, Avouac B, Bouvenot G, Devogelaer J, Eastell R, Fabris F, Gennari C, Jones E A, Kaufman J M, Lemmel E, Mazzuoli G, Reid D M, Ringe J D, Vanhaelst L, Ziegler R, Reginster J Y

出版信息

Calcif Tissue Int. 1996 Nov;59(5):323-7. doi: 10.1007/s002239900134.

DOI:10.1007/s002239900134
PMID:8849396
Abstract
摘要

相似文献

1
Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis.糖皮质激素性骨质疏松防治用药登记建议
Calcif Tissue Int. 1996 Nov;59(5):323-7. doi: 10.1007/s002239900134.
2
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science.糖皮质激素性骨质疏松防治药物登记建议：科学伦理与卓越性尊重小组的更新内容
Osteoporos Int. 2008 Sep;19(9):1247-50. doi: 10.1007/s00198-008-0670-7. Epub 2008 Jul 5.
3
Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.糖皮质激素性骨质疏松症的预防和治疗建议：2001年更新版。美国风湿病学会糖皮质激素性骨质疏松症特别委员会
Arthritis Rheum. 2001 Jul;44(7):1496-503. doi: 10.1002/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5.
4
Bisphosphonates and glucocorticoid-induced osteoporosis: implications for patients with respiratory diseases.双膦酸盐与糖皮质激素诱导的骨质疏松症：对呼吸系统疾病患者的影响
Thorax. 1998 May;53(5):331-2. doi: 10.1136/thx.53.5.331.
5
Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science.糖皮质激素性骨质疏松预防和治疗用药注册建议：科学伦理与卓越性小组的更新建议
Semin Arthritis Rheum. 2005 Aug;35(1):1-4. doi: 10.1016/j.semarthrit.2005.03.006.
6
[Drug therapy of secondary osteoporosis: glucocorticoid-induced osteoporosis].继发性骨质疏松症的药物治疗：糖皮质激素诱导的骨质疏松症
Nihon Rinsho. 2009 May;67(5):985-90.
7
[Randomized controlled trials for the prevention and treatment of glucocorticoid-induced osteoporosis].[预防和治疗糖皮质激素性骨质疏松症的随机对照试验]
Clin Calcium. 2006 Nov;16(11):1834-42.
8
[Guidelines on the management and treatment of glucocorticoid-induced osteoporosis].[糖皮质激素性骨质疏松症的管理与治疗指南]
Nihon Rinsho. 2011 Jul;69(7):1310-4.
9
[Glucocorticoid-induced osteoporosis].[糖皮质激素性骨质疏松症]
Orv Hetil. 2000 Jan 30;141(5):219-23.
10
Glucocorticoid-induced Osteoporosis.糖皮质激素性骨质疏松症
Rheum Dis Clin North Am. 2016 Feb;42(1):177-89, x. doi: 10.1016/j.rdc.2015.08.005. Epub 2015 Oct 24.

引用本文的文献

1
[Prophylaxis and therapy of the glucocorticoid-induced osteoporosis - a review of recent guidelines].[糖皮质激素诱导的骨质疏松症的预防与治疗——近期指南综述]
Wien Klin Wochenschr. 2011 Nov;123(21-22):633-44. doi: 10.1007/s00508-011-0042-8. Epub 2011 Aug 25.
2
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science.糖皮质激素性骨质疏松防治药物登记建议：科学伦理与卓越性尊重小组的更新内容
Osteoporos Int. 2008 Sep;19(9):1247-50. doi: 10.1007/s00198-008-0670-7. Epub 2008 Jul 5.
3

本文引用的文献

1
Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study.皮质类固醇诱导的小梁结构改变：一项骨组织形态计量学研究。
J Bone Miner Res. 1996 May;11(5):676-85. doi: 10.1002/jbmr.5650110516.
2
Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis.用于预防和治疗骨质疏松症的新化学实体注册建议。
Calcif Tissue Int. 1995 Oct;57(4):247-50. doi: 10.1007/BF00298877.
3
Available animal models of osteopenia--small and large.
Bone loss and glucocorticoid therapy in patients with respiratory disease.
呼吸系统疾病患者的骨质流失与糖皮质激素治疗
Thorax. 1999 Aug;54 Suppl 2(Suppl 2):S52-7. doi: 10.1136/thx.54.2008.s52.
4
Management of bone disease in patients on long term glucocorticoid therapy.长期接受糖皮质激素治疗患者的骨病管理
Gut. 1999 Jun;44(6):770-2. doi: 10.1136/gut.44.6.770.
Bone. 1995 Oct;17(4 Suppl):117S-123S. doi: 10.1016/8756-3282(95)00284-k.
4
Basic biomechanical measurements of bone: a tutorial.骨骼的基础生物力学测量：教程
Bone. 1993 Jul-Aug;14(4):595-608. doi: 10.1016/8756-3282(93)90081-k.
5
Connectivity of cancellous bone: assessment and mechanical implications.松质骨的连通性：评估及其力学意义
Bone. 1994 Sep-Oct;15(5):463-6. doi: 10.1016/8756-3282(94)90267-4.
6
Steroid-induced fractures and bone loss in patients with asthma.哮喘患者的类固醇诱导性骨折和骨质流失
N Engl J Med. 1983 Aug 4;309(5):265-8. doi: 10.1056/NEJM198308043090502.
7
Fractures after rheumatoid arthritis. A population-based study.类风湿关节炎后的骨折。一项基于人群的研究。
Arthritis Rheum. 1984 Dec;27(12):1353-61. doi: 10.1002/art.1780271205.
8
Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis.特发性和皮质类固醇诱导性骨质疏松症的微观解剖对比
Clin Orthop Relat Res. 1989 Jun(243):294-305.
9
Corticosteroid effects on proximal femur bone loss.皮质类固醇对股骨近端骨质流失的影响。
J Bone Miner Res. 1990 Dec;5(12):1211-6. doi: 10.1002/jbmr.5650051204.